These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 34061128)

  • 1. Remimazolam: a short-acting benzodiazepine for procedural sedation.
    Paton DM
    Drugs Today (Barc); 2021 May; 57(5):337-346. PubMed ID: 34061128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remimazolam: A Review in Procedural Sedation.
    Lee A; Shirley M
    Drugs; 2021 Jul; 81(10):1193-1201. PubMed ID: 34196946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remimazolam: First Approval.
    Keam SJ
    Drugs; 2020 Apr; 80(6):625-633. PubMed ID: 32274703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remimazolam versus traditional sedatives for procedural sedation: a systematic review and meta-analysis of efficacy and safety outcomes.
    Tang Y; Yang X; Yu Y; Shu H; Xu J; Li R; Zou X; Yuan S; Shang Y
    Minerva Anestesiol; 2022 Nov; 88(11):939-949. PubMed ID: 35785930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial.
    Rex DK; Bhandari R; Lorch DG; Meyers M; Schippers F; Bernstein D
    Dig Liver Dis; 2021 Jan; 53(1):94-101. PubMed ID: 33243567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures.
    Rogers WK; McDowell TS
    IDrugs; 2010 Dec; 13(12):929-37. PubMed ID: 21154153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy.
    Pambianco DJ; Borkett KM; Riff DS; Winkle PJ; Schwartz HI; Melson TI; Wilhelm-Ogunbiyi K
    Gastrointest Endosc; 2016 May; 83(5):984-92. PubMed ID: 26363333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic benefits of remimazolam compared to midazolam and propofol for procedural sedation in colonoscopies and bronchoscopies.
    Pedersen MH; Danø A; Englev E; Kattenhøj L; Munk E
    Curr Med Res Opin; 2023 May; 39(5):691-699. PubMed ID: 36999319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction and maintenance of procedural sedation in adults: focus on remimazolam injection.
    Chen W; Chen S; Huang Y
    Expert Rev Clin Pharmacol; 2021 Apr; 14(4):411-426. PubMed ID: 33686920
    [No Abstract]   [Full Text] [Related]  

  • 10. Remimazolam: its clinical pharmacology and evolving role in anesthesia and sedation practice.
    Masui K
    Curr Opin Anaesthesiol; 2024 Aug; 37(4):344-351. PubMed ID: 38841907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remimazolam - current knowledge on a new intravenous benzodiazepine anesthetic agent.
    Kim SH; Fechner J
    Korean J Anesthesiol; 2022 Aug; 75(4):307-315. PubMed ID: 35585830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laryngeal edema following remimazolam-induced anaphylaxis: a rare clinical manifestation.
    Hu X; Tang Y; Fang X
    BMC Anesthesiol; 2023 Mar; 23(1):99. PubMed ID: 36991317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled Remimazolam Potentiates Inhaled Remifentanil in Rodents.
    Bevans T; Deering-Rice C; Stockmann C; Rower J; Sakata D; Reilly C
    Anesth Analg; 2017 May; 124(5):1484-1490. PubMed ID: 28333705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sedation outcomes for remimazolam, a new benzodiazepine.
    Oka S; Satomi H; Sekino R; Taguchi K; Kajiwara M; Oi Y; Kobayashi R
    J Oral Sci; 2021 Jun; 63(3):209-211. PubMed ID: 34092775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of concurrent remifentanil on the sedative effects of remimazolam, midazolam and propofol in cynomolgus monkeys.
    Kops MS; Pesic M; Petersen KU; Schmalix WA; Stöhr T
    Eur J Pharmacol; 2021 Jan; 890():173639. PubMed ID: 33065095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Application and Research Progress of Remimazolam for Pediatric Patients.
    Bai C; Xu M; Guo Y; Jin Y; Zhao X
    Drug Des Devel Ther; 2024; 18():1221-1229. PubMed ID: 38645987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remimazolam: A Retrospective Study of Initial Safety and Recovery Data in Diverse Procedural Sedation.
    Johnson KL; Meyers JS; Mortensen GN; Steege JR; Mara KC; Brinkman NJ
    Clin Ther; 2024 Feb; 46(2):90-95. PubMed ID: 38071132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remimazolam: An Updated Review of a New Sedative and Anaesthetic.
    Hu Q; Liu X; Wen C; Li D; Lei X
    Drug Des Devel Ther; 2022; 16():3957-3974. PubMed ID: 36411859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychomotor Recovery Following Remimazolam-induced Sedation and the Effectiveness of Flumazenil as an Antidote.
    Chen X; Sang N; Song K; Zhong W; Wang H; Jiang J; Huang Y; Hu P
    Clin Ther; 2020 Apr; 42(4):614-624. PubMed ID: 32178858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.